Treatment of opioid-dependent pregnant women: clinical and research issues.

Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84

Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications. Addict Sci Clin Pract (2011) 1.67

Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics. Eur Addict Res (2012) 1.56

Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction (2012) 1.25

Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol (2013) 1.25

Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat (2010) 1.14

Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine. J Addict Dis (2010) 1.03

Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples. Am J Drug Alcohol Abuse (2009) 0.97

Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment. Eur Addict Res (2010) 0.97

Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict (2010) 0.95

Fetal neurobehavioral effects of exposure to methadone or buprenorphine. Neurotoxicol Teratol (2010) 0.94

Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study. Am J Drug Alcohol Abuse (2009) 0.93

Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict (2009) 0.92

Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women. Ther Drug Monit (2011) 0.89

Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction (2012) 0.88

Recent sex trade and injection drug use among pregnant opiate and cocaine dependent women in treatment: The significance of psychiatric comorbidity. Addict Disord Their Treat (2010) 0.87

Initial feasibility of a woman-focused intervention for pregnant african-american women. Int J Pediatr (2011) 0.87

Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes. Ther Drug Monit (2010) 0.86

Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.85

Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Addiction (2011) 0.85

The management of opioid dependence during pregnancy in rural and remote settings. CMAJ (2014) 0.84

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone. SAGE Open Med (2014) 0.80

Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addiction (2012) 0.78

Chronic in utero buprenorphine exposure causes prolonged respiratory effects in the guinea pig neonate. Neurotoxicol Teratol (2009) 0.77

The treatment of alcohol and opioid dependence in pregnant women. Curr Opin Psychiatry (2012) 0.77

Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates? Gend Med (2011) 0.77

Auricular acupuncture for chemically dependent pregnant women: a randomized controlled trial of the NADA protocol. Subst Abuse Treat Prev Policy (2012) 0.77

Evaluation and management of opioid dependence in pregnancy. Psychosomatics (2012) 0.77

Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population. BMJ Open (2016) 0.76

Postpartum changes in methadone maintenance dose. J Subst Abuse Treat (2014) 0.75

Cigarette Smoking and Neonatal Outcomes in Depressed and Non-Depressed Opioid-Dependent Agonist-Maintained Pregnant Patients. Addict Disord Their Treat (2011) 0.75

Case Presentations from the Addiction Academy. J Med Toxicol (2016) 0.75

Systematic Review of Interventions for Racial/Ethnic-Minority Pregnant Smokers. J Smok Cessat (2014) 0.75

Neonatal abstinence syndrome: Neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal. Dev Psychobiol (2017) 0.75

Polysubstance Use Among US Women of Reproductive Age Who Use Opioids for Nonmedical Reasons. Am J Public Health (2017) 0.75

The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat (1992) 29.45

A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction (2006) 8.57

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med (2006) 5.91

Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA (1998) 5.20

The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs (2003) 3.91

In utero antiepileptic drug exposure: fetal death and malformations. Neurology (2006) 3.64

Mechanisms of fatal opioid overdose. Addiction (1999) 3.60

A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry (2002) 2.64

Perinatal risks of untreated depression during pregnancy. Can J Psychiatry (2004) 2.50

Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am (1998) 2.33

The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol (2006) 2.31

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend (2005) 2.26

Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction (2006) 2.04

Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet (2002) 1.96

Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet. Drug Alcohol Depend (2000) 1.93

Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution. Drug Alcohol Depend (2005) 1.90

"Hello, may we help you?" A study of attrition prevention at the time of the first phone contact with substance-abusing clients. Am J Drug Alcohol Abuse (1990) 1.79

Pretreatment dropout as a function of treatment delay and client variables. Addict Behav (1995) 1.77

Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics (2006) 1.73

Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med (2006) 1.56

Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry (2000) 1.55

Assessment of opioid dependence with naloxone. Br J Addict (1988) 1.53

Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine. Clin Infect Dis (2006) 1.52

Methadone induction doses: are our current practices safe? J Addict Dis (2006) 1.50

Examining the limits of the buprenorphine interdosing interval: daily, every-third-day and every-fifth-day dosing regimens. Addiction (2001) 1.47

Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study. Am J Addict (2006) 1.47

Treatment of opioid-dependent pregnant women with buprenorphine. Addiction (2000) 1.41

The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev (1977) 1.40

Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction (1998) 1.32

The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clin Infect Dis (2003) 1.28

Cases of buprenorphine abuse in India. Acta Psychiatr Scand (1992) 1.24

Contrasting predictors of readiness for substance abuse treatment in adults and adolescents: a latent variable analysis of DATOS and DATOS-A participants. Drug Alcohol Depend (2005) 1.24

Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat (2006) 1.22

Interaction between buprenorphine and atazanavir or atazanavir/ritonavir. Drug Alcohol Depend (2007) 1.21

Perinatal addiction: outcome and management. Am J Obstet Gynecol (1977) 1.21

Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug Alcohol Depend (2003) 1.21

Short-term effects of early suckling and touch of the nipple on maternal behaviour. Early Hum Dev (1990) 1.19

Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes. Life Sci (1997) 1.17

Perinatal substance abusers. Psychological and social characteristics. J Nerv Ment Dis (1993) 1.17

Fetal response to maternal methadone administration. Am J Obstet Gynecol (2005) 1.14

Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.14

Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Drug Alcohol Depend (2005) 1.13

From telephone to office: intake attendance as a function of appointment delay. Addict Behav (2002) 1.11

Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors. Drug Metab Dispos (1998) 1.11

A comparison of three "interventions" on pretreatment dropout rates in an outpatient substance abuse clinic. Addict Behav (1999) 1.10

Identifying pregnant women at risk for early attrition from substance abuse treatment. J Subst Abuse Treat (2004) 1.10

Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates. J Matern Fetal Neonatal Med (2007) 1.10

Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients. Psychopharmacology (Berl) (1999) 1.09

Comparison of maternal absenteeism and infant illness rates among breast-feeding and formula-feeding women in two corporations. Am J Health Promot (1996) 1.08

Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans. Drug Alcohol Depend (2001) 1.08

Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: health, developmental, and social implications. J Pediatr (1981) 1.07

Modified directly observed therapy (MDOT) for injection drug users with HIV disease. Am J Addict (2002) 1.06

Fetal stress from methadone withdrawal. Am J Obstet Gynecol (1975) 1.05

Methadone disposition during the perinatal period in humans. Pharmacol Biochem Behav (1979) 1.04

Neonatal abstinence syndrome following abrupt cessation of breastfeeding. N Z Med J (1999) 1.04

Pregnancy in narcotics addicts treated by medical withdrawal. The methadone detoxification program. Am J Obstet Gynecol (1969) 1.03

Training primary health care professionals to provide buprenorphine and LAAM treatment. Subst Abus (2002) 1.02

Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans. Psychopharmacology (Berl) (1998) 1.01

Methadone metabolism by human placenta. Biochem Pharmacol (2004) 1.01

Endogenous opioids and attenuated hypothalamic-pituitary-adrenal axis responses to immune challenge in pregnant rats. J Neurosci (2005) 0.99

Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans. J Pharmacol Exp Ther (1996) 0.99

Alternate-day dosing during buprenorphine treatment of opioid dependence. Life Sci (1994) 0.98

Reduced activity of the noradrenergic system in the paraventricular nucleus at the end of pregnancy: implications for stress hyporesponsiveness. J Neuroendocrinol (2005) 0.97

Diagnosis and treatment of depression during pregnancy. CNS Spectr (2004) 0.96

Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans. Psychopharmacology (Berl) (2002) 0.96

Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. Am J Obstet Gynecol (1973) 0.95

Effect of opioid dependence pharmacotherapies on zidovudine disposition. Am J Addict (2001) 0.93

Analyses of methadone and other drugs in maternal and neonatal body fluids: use in evaluation of symptoms in a neonate of mother maintained on methadone. Am J Drug Alcohol Abuse (1974) 0.93

A comparative study of postpartum depression in abused and non-abused women. Arch Psychiatr Nurs (2005) 0.92

Chemical dependence and clinical depression in pregnancy. J Clin Psychol (1985) 0.92

Perinatal substance abuse: comments and perspectives. Semin Perinatol (1991) 0.92

Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices. Biol Psychiatry (2006) 0.91

Opioid antagonist challenges in buprenorphine maintained patients. Drug Alcohol Depend (1990) 0.91

Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation. Can Fam Physician (2001) 0.91

The accelerated intake: a method for increasing initial attendance to outpatient cocaine treatment. J Appl Behav Anal (1996) 0.91

Buprenorphine maintenance in pregnant opiate addicts. Eur Addict Res (1998) 0.90

A comparison of the effects of single- and split-dose methadone administration on the fetus: ultrasound evaluation. Int J Addict (1991) 0.89

Depression in pregnant drug-dependent women. NIDA Res Monogr (1982) 0.88

Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy. Obstet Gynecol (2007) 0.88

Methadone-related deaths in Western Australia 1993-99. Aust N Z J Public Health (2002) 0.87

Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction. AIDS (2005) 0.87

The effect of methadone and buprenorphine on human placental aromatase. Biochem Pharmacol (2006) 0.87

Assessing the needs of substance abusing women. Psychometric data on the psychosocial history. J Subst Abuse Treat (1999) 0.87

A new series of 13 buprenorphine-related deaths. Clin Biochem (2002) 0.86

Ketoconazole increases cocaine and opioid use in methadone maintained patients. Drug Alcohol Depend (2002) 0.86

Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns. J Soc Gynecol Investig (2006) 0.86

Dosing adjustments in postpartum patients maintained on buprenorphine or methadone. J Addict Med (2008) 0.85

Comparison of buprenorphine and methadone maintenance in opiate addicts. Eur Addict Res (1998) 0.85

Precipitated withdrawal by pentazocine in methadone-maintained volunteers. J Pharmacol Exp Ther (1993) 0.85

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry (1992) 0.85

Post-cesarean pain management of patients maintained on methadone or buprenorphine. Am J Addict (2006) 0.85

Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir. J Acquir Immune Defic Syndr (2003) 0.84

Methadone trough levels in pregnancy. Am J Obstet Gynecol (2002) 0.84

Methadone dosing and pregnancy: impact on program compliance. Int J Addict (1995) 0.83

In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine. Fundam Clin Pharmacol (1998) 0.83

Effect of buprenorphine on CYP3A activity in rat and human liver microsomes. Life Sci (2000) 0.83

Are the new SSRIs safe for pregnant women? Can Fam Physician (1998) 0.82

Fluoxetine addition to methadone in addicts: pharmacokinetic aspects. Ther Drug Monit (1996) 0.81

A comparison of four buprenorphine dosing regimens using open-dosing procedures: is twice-weekly dosing possible? Addiction (2000) 0.81

The relationship between infant feeding method and maternal role adjustment. J Nurse Midwifery (1988) 0.81

A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction (2006) 8.57

Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84

Usage and longitudinal effectiveness of a Web-based self-help cognitive behavioral therapy program for panic disorder. J Med Internet Res (2005) 3.81

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nat Med (2011) 3.60

Energy drink consumption and increased risk for alcohol dependence. Alcohol Clin Exp Res (2010) 3.14

A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry (2006) 2.98

Drug exposure opportunities and use patterns among college students: results of a longitudinal prospective cohort study. Subst Abus (2008) 2.95

Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women. Exp Clin Psychopharmacol (2007) 2.77

The cost-effectiveness of alendronate in the management of osteoporosis. Bone (2007) 2.75

Clinical implications of reinforcement as a determinant of substance use disorders. Annu Rev Psychol (2004) 2.74

Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. J Clin Oncol (2008) 2.57

Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. Cancer Treat Rev (2008) 2.48

Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Addiction (2012) 2.47

A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release. Addiction (2008) 2.45

Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. J Addict Med (2015) 2.38

A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. JAMA Psychiatry (2013) 2.29

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend (2005) 2.26

A pilot study on voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum. Nicotine Tob Res (2004) 2.23

Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry (2003) 2.20

Increased alcohol consumption, nonmedical prescription drug use, and illicit drug use are associated with energy drink consumption among college students. J Addict Med (2010) 2.19

Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict (2008) 2.17

The occurrence of cannabis use disorders and other cannabis-related problems among first-year college students. Addict Behav (2007) 2.11

A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat (2009) 2.03

Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus. Clin Cancer Res (2008) 1.91

Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit (2009) 1.89

Distance traveled to outpatient drug treatment and client retention. J Subst Abuse Treat (2003) 1.86

Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction (2007) 1.83

Computerized versus in-person brief intervention for drug misuse: a randomized clinical trial. Addiction (2014) 1.75

Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nat Med (2007) 1.74

Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy (2008) 1.73

Why don't out-of-treatment individuals enter methadone treatment programmes? Int J Drug Policy (2008) 1.73

Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction (2010) 1.71

Reovirus activates human dendritic cells to promote innate antitumor immunity. J Immunol (2008) 1.70

Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol (2003) 1.70

Perceived harmfulness predicts nonmedical use of prescription drugs among college students: interactions with sensation-seeking. Prev Sci (2008) 1.65

Nonmedical Use of Prescription Stimulants and Analgesics: Associations with Social and Academic Behaviors among College Students. J Drug Issues (2008) 1.63

Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction (2005) 1.57

A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3. Hepatology (2008) 1.56

A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist (2014) 1.55

Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients. J Clin Psychopharmacol (2009) 1.55

Maternal smoking and its association with birth weight. Obstet Gynecol (2005) 1.55

Educating nursing home staff on fracture prevention: a cluster randomised trial. Age Ageing (2007) 1.54

A Study of Methadone Maintenance For Male Prisoners: 3-Month Postrelease Outcomes. Crim Justice Behav (2008) 1.54

Prevalence and predictors of persistent suicide ideation, plans, and attempts during college. J Affect Disord (2010) 1.54

Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma. Nat Biotechnol (2012) 1.52

Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. Am J Public Health (2013) 1.52

A randomized controlled trial of interim methadone maintenance: 10-Month follow-up. Drug Alcohol Depend (2006) 1.51

Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction (2008) 1.51

Attitudes toward buprenorphine and methadone among opioid-dependent individuals. Am J Addict (2008) 1.51

Sociodemographic correlates of energy drink consumption with and without alcohol: results of a community survey. Addict Behav (2010) 1.50

Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J Neurosci (2012) 1.48

Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients. Sci Transl Med (2012) 1.46

Superusers in social networks for smoking cessation: analysis of demographic characteristics and posting behavior from the Canadian Cancer Society's smokers' helpline online and StopSmokingCenter.net. J Med Internet Res (2012) 1.45

Biochemical verification of smoking status in pregnant and recently postpartum women. Exp Clin Psychopharmacol (2007) 1.45

Firesetting in adolescence and being aggressive, shy, and rejected by peers: new epidemiologic evidence from a national sample survey. J Am Acad Psychiatry Law (2003) 1.44

Financial incentives for smoking cessation among pregnant and newly postpartum women. Prev Med (2011) 1.44

Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med (2012) 1.43

Premature discharge from methadone treatment: patient perspectives. J Psychoactive Drugs (2009) 1.42

Communication about sexual problems and sexual concerns in ovarian cancer: a qualitative study. West J Med (2002) 1.40

Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Miner Res (2003) 1.39

Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer Res (2007) 1.37

Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend (2003) 1.36

Web-assisted tobacco interventions: empowering change in the global fight for the public's (e)Health. J Med Internet Res (2008) 1.36

Suicide ideation among college students: a multivariate analysis. Arch Suicide Res (2009) 1.35

Skeletal complications and survival in renal cancer patients with bone metastases. Bone (2010) 1.32

Educational disadvantage and cigarette smoking during pregnancy. Drug Alcohol Depend (2009) 1.32

Nonmedical use of prescription stimulants during college: four-year trends in exposure opportunity, use, motives, and sources. J Am Coll Health (2012) 1.32

Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend (2006) 1.31

Sharing and selling of prescription medications in a college student sample. J Clin Psychiatry (2010) 1.31

In-treatment vs. out-of-treatment opioid dependent adults: drug use and criminal history. Am J Drug Alcohol Abuse (2008) 1.31

Maintaining Superior Follow-Up Rates in a Longitudinal Study: Experiences from the College Life Study. Int J Mult Res Approaches (2012) 1.27

Predictors of methadone treatment retention from a multi-site study: a survival analysis. Drug Alcohol Depend (2011) 1.26

Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction (2012) 1.25